ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,127.20
      0.88%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.24
      0.10%
      Bitcoin
      64,487.66
      0.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. REGENXBIO Inc (RGNX)

      7. REGENXBIO Inc (RGNX) News

      RGNX REGENXBIO Inc

      16.06
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:09:35
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      REGENXBIO Inc RGNX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 16.06 04:09:35
      Open Price Low Price High Price Close Price Prev Close
      16.06
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/24/202407:05PRNUSREGENXBIO to Participate in Chardan's 8th Annual Genetic..
      3/28/202407:05PRNUSREGENXBIO Announces Lancet Publication of Phase I/IIa Study..
      3/27/202416:05PRNUSREGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD..
      3/11/202408:00EDGAR2Form 8-K - Current report
      3/11/202407:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
      3/08/202406:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/07/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202406:03EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
      3/06/202423:20PRNUSREGENXBIO Announces Pricing of Upsized Public Offering of..
      3/06/202416:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/06/202416:10PRNUSREGENXBIO Announces Proposed Public Offering of Common Stock
      3/05/202416:26EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202407:05PRNUSREGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM..
      2/29/202416:57PRNUSREGENXBIO to Host Webcast Event to Discuss New Interim..
      2/27/202416:54EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/27/202416:10EDGAR2Form 8-K - Current report
      2/27/202416:05PRNUSREGENXBIO Reports Fourth Quarter and Full Year 2023..
      2/21/202407:05PRNUSREGENXBIO to Host Conference Call on February 27 to Discuss..
      2/16/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202411:40PRNUSREGENXBIO Announces Pivotal Trial of RGX-121 for the..
      2/07/202407:05PRNUSREGENXBIO Announces Completion of Enrollment in Cohort 2 and..
      1/31/202407:05PRNUSREGENXBIO Announces Presentations at the 20th Annual..
      1/18/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/16/202416:22EDGAR2Form 144 - Report of proposed sale of securities
      1/16/202414:47PRNUSREGENXBIO Announces Positive Interim Data from Phase II..
      1/10/202407:05PRNUSREGENXBIO Announces Presentation at the Hawaiian Eye and..
      1/08/202407:05PRNUSU.S. District Court Issues Decision on REGENXBIO and..
      1/04/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202416:21EDGAR2Form 144 - Report of proposed sale of securities
      12/21/202313:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202316:29EDGAR2Form 144 - Report of proposed sale of securities
      11/29/202307:05PRNUSREGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE®..
      11/08/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/08/202316:10EDGAR2Form 8-K - Current report
      11/08/202316:05PRNUSREGENXBIO Announces Updated Strategic Plans and Third..
      11/07/202307:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
      11/03/202318:53PRNUSREGENXBIO Presents Positive One Year Data from Phase II..
      11/01/202307:05PRNUSREGENXBIO to Host Conference Call on November 8 to Discuss..
      10/30/202307:05PRNUSREGENXBIO Announces Presentations at the American Academy of..
      10/05/202307:05PRNUSREGENXBIO to Participate in the Jefferies CNS/Neuro Summit
      10/03/202316:05PRNUSREGENXBIO Presents Interim Clinical Data from Phase I/II..
      9/26/202307:05PRNUSREGENXBIO Announces Presentations at the 28th Annual..
      9/05/202307:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
      9/01/202316:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      9/01/202316:12EDGAR2Form 8-K - Current report
      8/30/202307:05PRNUSInitial Clinical Data of First Pediatric CLN2 Patient Dosed..
      8/23/202316:05PRNUSREGENXBIO Announces Presentations at the Society for the..

      Your Recent History

      NASDAQ
      RGNX
      REGENXBIO
      Delayed Upgrade Clock